Health care stocks started the week mixed amid a smattering of earnings, trial data and other news.AstraZeneca (AZN - Get Report) said Monday that its heart drug Brilinta worked better than Bristol-Myers Squibb's (BMY - Get Report) and Sanofi-Aventis' (SNY - Get Report) blockbuster blood-thinner Plavix in a study.
Health Winners and Losers: AstraZeneca
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.